Ingrid Lekander

787 total citations
21 papers, 457 citations indexed

About

Ingrid Lekander is a scholar working on Economics and Econometrics, Epidemiology and Rheumatology. According to data from OpenAlex, Ingrid Lekander has authored 21 papers receiving a total of 457 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Economics and Econometrics, 5 papers in Epidemiology and 4 papers in Rheumatology. Recurrent topics in Ingrid Lekander's work include Health Systems, Economic Evaluations, Quality of Life (7 papers), Acute Ischemic Stroke Management (5 papers) and Biosimilars and Bioanalytical Methods (4 papers). Ingrid Lekander is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (7 papers), Acute Ischemic Stroke Management (5 papers) and Biosimilars and Bioanalytical Methods (4 papers). Ingrid Lekander collaborates with scholars based in Sweden, United Kingdom and Denmark. Ingrid Lekander's co-authors include Fredrik Borgström, O. Ström, Patrik Sobocki, Katharina S. Sunnerhagen, Carl Willers, Mia von Euler, Bo Runeson, Hélène Pessah-Rasmussen, Mikael Lilja and Jes Olesen and has published in prestigious journals such as PLoS ONE, European Journal of Neuroscience and Bone.

In The Last Decade

Ingrid Lekander

20 papers receiving 436 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ingrid Lekander Sweden 12 92 80 72 70 61 21 457
Lisa Engel Canada 11 108 1.2× 28 0.3× 101 1.4× 59 0.8× 97 1.6× 30 556
Daniel Prefasi Spain 14 87 0.9× 53 0.7× 63 0.9× 40 0.6× 41 0.7× 26 432
SJ Cano United Kingdom 6 72 0.8× 58 0.7× 69 1.0× 141 2.0× 33 0.5× 14 643
Neesha Harnam United States 11 97 1.1× 110 1.4× 59 0.8× 95 1.4× 94 1.5× 16 776
Tyler G. Kinzy United States 15 42 0.5× 89 1.1× 101 1.4× 60 0.9× 29 0.5× 33 633
T. Michelle Brown United States 17 30 0.3× 63 0.8× 55 0.8× 107 1.5× 84 1.4× 46 862
L. Humphrey United Kingdom 11 59 0.6× 45 0.6× 67 0.9× 235 3.4× 126 2.1× 28 664
Jonathan Goddard United Kingdom 14 79 0.9× 71 0.9× 67 0.9× 40 0.6× 21 0.3× 19 598
Victoria Ruffing United States 7 44 0.5× 28 0.3× 47 0.7× 54 0.8× 223 3.7× 9 615
Jennifer Petrillo United States 11 87 0.9× 78 1.0× 77 1.1× 43 0.6× 27 0.4× 32 617

Countries citing papers authored by Ingrid Lekander

Since Specialization
Citations

This map shows the geographic impact of Ingrid Lekander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingrid Lekander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingrid Lekander more than expected).

Fields of papers citing papers by Ingrid Lekander

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingrid Lekander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingrid Lekander. The network helps show where Ingrid Lekander may publish in the future.

Co-authorship network of co-authors of Ingrid Lekander

This figure shows the co-authorship network connecting the top 25 collaborators of Ingrid Lekander. A scholar is included among the top collaborators of Ingrid Lekander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingrid Lekander. Ingrid Lekander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lekander, Ingrid, Mia von Euler, & Katharina S. Sunnerhagen. (2020). Association of prestroke medicine use and health outcomes after ischaemic stroke in Sweden: a registry-based cohort study. BMJ Open. 10(3). e036159–e036159. 2 indexed citations
2.
Willers, Carl, Katharina S. Sunnerhagen, Ingrid Lekander, & Mia von Euler. (2018). The Association of Pre-stroke Psychosis and Post-stroke Levels of Health, Resource Utilization, and Care Process: A Register-Based Study. Frontiers in Neurology. 9. 1042–1042. 13 indexed citations
3.
Willers, Carl, Ingrid Lekander, Elisabeth Ekstrand, et al.. (2018). Sex as predictor for achieved health outcomes and received care in ischemic stroke and intracerebral hemorrhage: a register-based study. Biology of Sex Differences. 9(1). 11–11. 35 indexed citations
4.
Lekander, Ingrid, Carl Willers, Elisabeth Ekstrand, et al.. (2017). Hospital comparison of stroke care in Sweden: a register-based study. BMJ Open. 7(9). e015244–e015244. 11 indexed citations
5.
Lekander, Ingrid, Carl Willers, Mia von Euler, et al.. (2017). Relationship between functional disability and costs one and two years post stroke. PLoS ONE. 12(4). e0174861–e0174861. 67 indexed citations
6.
Henry, Nathaniel, et al.. (2015). Cost‐effectiveness analysis of a low‐dose contraceptive levonorgestrel intrauterine system in Sweden. Acta Obstetricia Et Gynecologica Scandinavica. 94(8). 884–890. 5 indexed citations
7.
Henry, Nathaniel, Max Schlueter, Julia Lowin, et al.. (2014). Cost of unintended pregnancy in Norway: a role for long-acting reversible contraception. Journal of Family Planning and Reproductive Health Care. 41(2). 109–115. 26 indexed citations
8.
9.
Lekander, Ingrid, Fredrik Borgström, J Lysholm, et al.. (2012). The cost-effectiveness of TNF-inhibitors for the treatment of rheumatoid arthritis in Swedish clinical practice. The European Journal of Health Economics. 14(6). 863–873. 18 indexed citations
10.
Kobelt, Gisela, et al.. (2011). Cost-effectiveness of etanercept treatment in early active rheumatoid arthritis followed by dose adjustment. International Journal of Technology Assessment in Health Care. 27(3). 193–200. 27 indexed citations
11.
Moreno, Santiago, J.J. González, Ingrid Lekander, et al.. (2010). Cost-effectiveness of optimized background therapy plus maraviroc for previously treated patients with R5 HIV-1 infection from the perspective of the Spanish health care system. Clinical Therapeutics. 32(13). 2232–2245. 3 indexed citations
12.
Lekander, Ingrid, et al.. (2010). Cost-effectiveness of real-world infliximab use in patients with rheumatoid arthritis in Sweden. International Journal of Technology Assessment in Health Care. 26(1). 54–61. 27 indexed citations
13.
Lekander, Ingrid, Fredrik Borgström, O. Ström, Niklas Zethraeus, & John А. Kanis. (2009). Cost-effectiveness of hormone replacement therapy for menopausal symptoms in the UK. Menopause international. 15(1). 19–25. 10 indexed citations
14.
Lekander, Ingrid, Fredrik Borgström, O. Ström, Niklas Zethraeus, & John А. Kanis. (2009). Cost-Effectiveness of Hormone Therapy in the United States. Journal of Women s Health. 18(10). 1669–1677. 20 indexed citations
15.
Lekander, Ingrid, Jacob J. van den Berg, A. B. Christie, Clifford Leen, & Mark Nelson. (2008). A cost-effectiveness analysis of Maraviroc in treatment-experienced HIV patients in Scotland. Journal of the International AIDS Society. 11(Suppl 1). P315–P315.
16.
Lekander, Ingrid, Fredrik Borgström, O. Ström, Niklas Zethraeus, & John А. Kanis. (2007). Cost effectiveness of hormone therapy in women at high risks of fracture in Sweden, the US and the UK—Results based on the Women's Health Initiative randomised controlled trial. Bone. 42(2). 294–306. 22 indexed citations
17.
Olesen, Jes, Ingrid Lekander, & Patrik Sobocki. (2007). Resource allocation to brain research in Denmark: an example for other European countries. European Journal of Neurology. 14(6). 667–671. 2 indexed citations
18.
Olesen, Jes, Ingrid Lekander, P Andlin‐Sobocki, & Bengt Jönsson. (2007). Funding of Headache Research in Europe. Cephalalgia. 27(9). 995–999. 29 indexed citations
19.
Sobocki, Patrik, et al.. (2006). Resource allocation to brain research in Europe (RABRE). European Journal of Neuroscience. 24(10). 2691–2693. 35 indexed citations
20.
Sobocki, Patrik, Ingrid Lekander, Fredrik Borgström, O. Ström, & Bo Runeson. (2006). The economic burden of depression in Sweden from 1997 to 2005. European Psychiatry. 22(3). 146–152. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lisa Engel Breakdown of academic impact, for papers by Daniel Prefasi Breakdown of academic impact, for papers by SJ Cano Breakdown of academic impact, for papers by Neesha Harnam Breakdown of academic impact, for papers by Tyler G. Kinzy Breakdown of academic impact, for papers by T. Michelle Brown Breakdown of academic impact, for papers by L. Humphrey Breakdown of academic impact, for papers by Jonathan Goddard Breakdown of academic impact, for papers by Victoria Ruffing Breakdown of academic impact, for papers by Jennifer Petrillo
Rankless by CCL
2026